Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.75M Sell
9,044
-260
-3% -$45.3K 0.03% 432
2026
Q1
$1.59M Sell
9,304
-1,276
-12% -$249K 0.04% 423
2025
Q4
$2.38M Buy
10,580
+5,455
+106% +$1.19M 0.05% 319
2025
Q3
$973K Sell
5,125
-1,102
-18% -$200K 0.03% 381
2025
Q2
$981K Buy
6,227
+4,819
+342% +$725K 0.03% 406
2025
Q1
$248K Sell
1,408
-397
-22% -$77K 0.02% 475
2024
Q4
$355K Buy
+1,805
New +$381K 0.02% 444

Other funds holding IQV

Callan Family Office's IQV Position: Q2 2026 in Review

Callan Family Office reduced its IQVIA (IQV) stake by 2.8% in Q2 2026, selling an estimated $45.3K and leaving 9,044 shares worth $1.75M. The position accounts for 0.03% of the portfolio, ranked #432.

Callan Family Office first reported a position in IQV in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.38M in Q4 2025. 1,085 funds tracked by Wall St. Rank hold IQV as of Q2 2026.

  • Callan Family Office held 9,044 shares of IQVIA worth $1.75M as of Q2 2026.
  • Callan Family Office sold 260 IQVIA shares in Q2 2026, an estimated $45.3K.
  • IQVIA made up 0.03% of Callan Family Office's portfolio in Q2 2026, its #432 holding.
  • Callan Family Office first reported a position in IQVIA in Q4 2024 and has held it in 7 quarters since.
  • Callan Family Office's IQVIA position peaked at $2.38M in Q4 2025.
  • 1,085 funds tracked by Wall St. Rank held IQVIA as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.